CONSIDER IT SOLVED It’s a bold statement given the complexity of communications in the biopharmaceutical industry. Every day, we fulfill this promise by solving business challenges for our clients, from advancing corporate reputation to explaining the science and economics of innovation. WE ARE SPECIALISTS We provide corporate communications and PR services to biopharmaceutical companies. We work exclusively in healthcare, applying our knowledge of science, medicine and the media. We gravitate toward companies with compelling missions and strong science. Clients involve us in diverse aspects of their business. OUR BUSINESS ACUMEN SETS US APART Collectively, we have worked at some of the world’s leading pharmaceutical and biotechnology companies, PR firms and patient organizations. Our senior-level team has the breadth of experience and depth of understanding to support your business. OUR VALUES ARE “OLD SCHOOL” We work hard and challenge ourselves to exceed expectations at every level. We are strategic in our thinking and disciplined in our execution. We pay attention to the details and produce clear and precise content. We make sure you have access to us whenever you need us. OUR APPROACH IS “NEW SCHOOL” We use a modern and integrated approach to accelerate your business success. Communications is a constantly evolving conversation with information flowing across audiences, geographies and media. The story belongs to the community, and your voice is one among many. Members from our team are certified in healthcare regulatory compliance for Public Relations, Digital Promotion, and Advertising/Promotion through the Center for Communication Compliance.
Looking for a particular SmithSolve employee's phone or email?
The SmithSolve annual revenue was $7 million in 2026.
Alex van Rees is the Vice President of Client Service of SmithSolve.
17 people are employed at SmithSolve.
SmithSolve is based in Morristown, New Jersey.
The NAICS codes for SmithSolve are [54182, 541, 541820, 5418, 54].
The SIC codes for SmithSolve are [87, 874].